Synopsis of recent research by authors named "Geraldine Duc"
- Geraldine Duc's recent research focuses primarily on the development and clinical application of gadolinium-based nanoparticles (AGuIX) as theranostic agents that enhance radiotherapy's effectiveness, particularly for brain metastases and glioblastoma patients.
- Her studies outline the safety and efficacy of AGuIX nanoparticles in various clinical trials, demonstrating their potential to improve imaging contrast in tumors and radiosensitization, leading to better outcomes in treatments like chemoradiotherapy.
- The innovative use of advanced imaging techniques, such as MRI and X-ray phase-contrast tomography, aims to better understand nanoparticle distribution and optimize therapeutic strategies, informing future research and applications in cancer treatment.
